Ana Vanessa Nascimento

Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles

Ana Vanessa Nascimento, Amit Singh, Hassan Bousbaa et al. · Acta Biomaterialia · 2016 · 121 citations · Full text

Pharmacy, Oncology, Pharmaceutics +16

<i>Mad2</i> Checkpoint Gene Silencing Using Epidermal Growth Factor Receptor-Targeted Chitosan Nanoparticles in Non-Small Cell Lung Cancer Model

Ana Vanessa Nascimento, Amit Singh, Hassan Bousbaa et al. · Molecular Pharmaceutics · 2014 · 67 citations · Full text

Pharmacy, Molecular Biology, Oncology +17

Biodistribution and Pharmacokinetics of <i>Mad2</i> siRNA-loaded EGFR-Targeted Chitosan Nanoparticles in Cisplatin Sensitive and Resistant Lung Cancer Models

Ana Vanessa Nascimento, Florence Gattacceca, Amit Singh et al. · Nanomedicine · 2016 · 59 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

<i>In Vitro</i> Targeted Imaging and Delivery of Camptothecin Using Cetuximab-Conjugated Multifunctional Plga-Zns Nanoparticles

V. G. Deepagan, Bruno Sarmento, Deepthy Menon et al. · Nanomedicine · 2012 · 46 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Repeated Administration of Clinically Relevant Doses of the Prescription Opioids Tramadol and Tapentadol Causes Lung, Cardiac, and Brain Toxicity in Wistar Rats

Joana Barbosa, Juliana Faria, Fernanda Garcez et al. · Pharmaceuticals · 2021 · 30 citations · Full text

Pharmacy, Pharmacology, Toxicology +17